Health tech Lizzy Lawrence STAT Plus: FDA approves TriClip for tricuspid heart valve disease, pitting Abbott against Edwards
Health tech Lizzy Lawrence STAT Plus: FDA clears digital stethoscope company’s AI algorithm for heart failure
Health Deborah Balthazar Disparities in donor acceptance rates point to need for more equitable heart transplant care
Health Elaine Chen STAT Plus: Despite new Wegovy coverage, Medicare patients may face high drug costs and other hurdles
Pharma Elaine Chen STAT Plus: Obesity drug Wegovy gets FDA approval to add cardiovascular benefits on its label
In the Lab Elaine Chen Microplastics found in blood vessels linked to greater risk of heart problems, study finds
Health Annalisa Merelli Niacin has long been a public health darling. But an excess could be bad for the heart, study suggests
Health tech Mario Aguilar STAT Plus: Digital tools helped lower blood pressure in marginalized patient groups
First Opinion Arthur L. Kellermann The health care system is ignoring world’s most promising approach to preventing cardiovascular disease
Health Elaine Chen Stem cell study offers clue to South Asians’ increased risk of cardiovascular disease
Business Tara Bannow STAT Plus: Lasers, cardiology, clinical trials: 2023’s top private equity targets
Health Gina Ryder Cardiac psychologists are pushing to protect heart patients’ often-overlooked mental health
Health Elaine Chen STAT Plus: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds
Health Elaine Chen People with congenital heart disease are living longer — but facing new threat of heart failure
Health tech Lizzy Lawrence STAT Plus: FDA approves Medtronic high blood pressure device despite a negative advisory panel vote
Biotech Matthew Herper STAT Plus: Eli Lilly’s chief scientist on new obesity drug data, gene editing, and a potential new heart drug
Pharma Elaine Chen STAT Plus: Novo Nordisk wants to be a cardiovascular company, too, with sights set on inflammation
Biotech Elaine Chen STAT Plus: Anthos stroke drug appears safer than common blood thinner in mid-stage trial
Health Matthew Herper STAT Plus: After decades in use, heart stents finally beat placebo. It took a bold researcher
Health Deborah Balthazar Second recipient of genetically modified pig heart dies, six weeks after surgery
Health Theresa Gaffney Extreme heat could lead to 233% increase in U.S. excess cardiovascular deaths, study says
Health tech Lizzy Lawrence STAT Plus: Boston Scientific’s drug-coated balloon may reduce risk of heart attack